23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
Board memebers quit as founder Anne Wojcicki works to come up with an acceptable financial offer to purchase its remaining ...
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ: ME) regarding whether the board of directors and the co-founder and current CEO ...
2don MSN
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback